Skip to content
BridgeBio Pharma, Inc. (BBIO) Stock Price, Key Stats & Insider Trading
Home / Companies / BBIO BBI
BridgeBio Pharma, Inc. (BBIO) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d) Watch BBIO
Latest BBIO Insider Trades
About BridgeBio Pharma, Inc. (BBIO) BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Headquarters PALO ALTO, CA
Employees 839
Listed 2019
Exchange XNAS https://www.bridgebio.com SEC filings for BBIO on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 31 427,343 $33.00M Grant or award 24 111,204 Option exercise 26 720,072
BBIO Insider Transactions (Form 4) 76 93 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Sep 4, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 14,525
Recent BBIO Form 8-K Filings 5
Recent BBIO Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 Director, Officer 30,000 $2.49M View on EDGAR Aug 18, 2026 NEIL KUMAR Director, Officer
BBIO Insider Trading - FAQ
What is the latest insider trade for BBIO? BridgeBio Pharma, Inc. (BBIO) had 22 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for BBIO runs to 93 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BBIO stock? No insider purchases of BBIO were filed in the last 90 days.
How many insiders are selling BBIO stock? 31 insider sales of BBIO were filed in the last 90 days, totaling $33.00M.
Where can I see BBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BBIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BBIO insider buys? Create a free InsiderAlpha account and press Watch on this page to add BBIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BBIO insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $1.21M
Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $100K
Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $679K
Aug 19, 2026
NK Neil Kumar - Officer Open-market sale $152K
Aug 19, 2026
NK Neil Kumar - Officer Open-market sale $9K
Aug 19, 2026
Market cap $14.97B
P/E ratio -
Dividend yield -
Average volume 3.19M
52 week high $93.42
52 week low $48.78
Today's high $80.55
Today's low $76.34
Open $79.99
Volume 1.96M
Previous close $78.68
Shares outstanding 195.49M Market cap
$14.97B
839 employees
BBIO Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 31 sales totaling $33.00M.
Most-Active BBIO Insiders - Last 90 Days 10 Tax withholding / forfeiture 4 64,520
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Sep 4, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 5,475 $51.85 $284K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 2,300 $51.95 $119K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 16,800 $53.16 $893K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 900 $53.80 $48K
Sep 4, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 14,558 $51.16 $745K
Sep 4, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 5,442 $51.85 $282K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 2,300 $51.96 $120K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 16,900 $53.16 $898K
Sep 5, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 800 $53.80 $43K
Aug 21, 2025 TT Thomas Trimarchi - Officer Open-market sale Common Stock 42,237 $49.48 $2.09M
Aug 20, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 25,728 $48.81 $1.26M
Aug 20, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 428 $49.25 $21K
Aug 16, 2025 TT Thomas Trimarchi - Officer Tax withholding / forfeiture Common Stock 21,317 $51.32 $1.09M
Aug 18, 2025 TT Thomas Trimarchi - Officer Open-market sale Common Stock 15,380 $50.14 $771K
Aug 18, 2025 TT Thomas Trimarchi - Officer Open-market sale Common Stock 1,973 $50.94 $101K
Aug 16, 2025 NK Neil Kumar - Officer Option exercise Common Stock 64,697 - -
Aug 16, 2025 NK Neil Kumar - Officer Tax withholding / forfeiture Common Stock 32,855 $51.32 $1.69M
Aug 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 33,544 $0.00 -
Aug 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 19,599 $0.00 -
Aug 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 11,554 $0.00 -
Aug 16, 2025 MA Maricel Apuli - Officer Tax withholding / forfeiture Common Stock 4,781 $51.32 $245K
Aug 7, 2025 MA Maricel Apuli - Officer Open-market sale Common Stock 1,000 $45.44 $45K
Aug 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 6,784 $45.09 $306K
Aug 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 13,216 $45.64 $603K
Aug 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 11,795 $45.88 $541K
Aug 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 8,205 $46.71 $383K
Aug 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 6,784 $45.09 $306K
Aug 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 13,216 $45.64 $603K
Aug 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 11,795 $45.88 $541K
Aug 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 8,205 $46.71 $383K
Aug 5, 2025 AE Andrea Ellis Option exercise Common Stock 17,167 $16.75 $288K
Aug 5, 2025 AE Andrea Ellis Open-market sale Common Stock 17,167 $49.00 $841K
Aug 5, 2025 AE Andrea Ellis Option exercise Stock Option (right to buy) 17,167 $0.00 -
Jul 1, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 18,300 $42.50 $778K
Jul 1, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 1,700 $42.88 $73K
Jul 2, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 20,000 $42.73 $855K
Jul 1, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 18,400 $42.51 $782K
Jul 1, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 1,600 $42.89 $69K
Jul 2, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 20,000 $42.73 $855K
Jun 24, 2025 FM Frank McCormick Open-market sale Common Stock 100,000 $44.23 $4.42M
Jun 20, 2025 CH Charles J. Homcy Grant or award Stock Option (Right to Buy) 8,425 $0.00 -
Jun 20, 2025 FM Frank McCormick Grant or award Stock Option (Right to Buy) 8,425 $0.00 -
Jun 20, 2025 FH Fred Hassan Grant or award Common Stock 6,589 $0.00 -
Jun 20, 2025 FH Fred Hassan Grant or award Stock Option (Right to Buy) 8,425 $0.00 -
Jun 20, 2025 EA Eric Aguiar Grant or award Common Stock 6,589 $0.00 -
Jun 20, 2025 EA Eric Aguiar Grant or award Stock Option (Right to Buy) 8,425 $0.00 -
Dec 30, 2024 AS Ali J. Satvat Option exercise Common Stock 79,702 $10.99 $876K
Dec 30, 2024 AS Ali J. Satvat Option exercise Common Stock 39,851 $16.68 $665K
Dec 30, 2024 AS Ali J. Satvat Option exercise Common Stock 39,851 $26.21 $1.04M
Dec 30, 2024 AS Ali J. Satvat Option exercise Stock Option (Right to Buy) 79,702 $0.00 -
Dec 30, 2024 AS Ali J. Satvat Option exercise Stock Option (Right to Buy) 39,851 $0.00 -
Dec 30, 2024 AS Ali J. Satvat Option exercise Stock Option (Right to Buy) 39,851 $0.00 -
Dec 24, 2024 NK Neil Kumar - Officer Gift Common Stock 4,685,725 $0.00 -
Dec 24, 2024 NK Neil Kumar - Officer Gift Common Stock 4,685,725 $0.00 -
Dec 10, 2024 NK Neil Kumar - Officer Grant or award Restricted Stock Units 121,951 $0.00 -
Nov 19, 2024 NK Neil Kumar - Officer Open-market sale Common Stock 25,514 $22.39 $571K
Nov 19, 2024 NK Neil Kumar - Officer Open-market sale Common Stock 1,875 $22.76 $43K
$ELAN
Elanco Animal Health Inc